Skip to main content

Table 4 Receiver operator characteristic curve analysis of all biomarkers for predicting events (death/LVAD implantation/transplant).

From: Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy

Biomarker AUC 95% CI P
sST2 0.76 (0.59 - 0.93) 0.001
NT-proBNP 0.53 (0.32 - 0.74) 0.38
hsTnI 0.61 (0.40 - 0.81) 0.15
eTnI 0.64 (0.44 - 0.84) 0.08
cys-C 0.63 (0.42 - 0.83) 0.11
MPO 0.63 (0.43 - 0.83) 0.10
  1. AUC, area under the curve; CI, confidence intervals; cys-C, cystatin C; eTnI, experimental research prototype Troponin I; hsTnI, highly sensitive Troponin I; MPO, myeloperoxidase; NT-proBNP, amino terminal cleavage fragment of B-type natriuretic peptide; sST2, soluble ST2.